VitaSpring Biomedical Co. Ltd.
VSBC
$1.00
$0.000.00%
OTC PK
| 04/30/2023 | 10/31/2022 | 07/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 179.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 179.13% |
| Cost of Revenue | -- | -- | -- | -- | 213.61% |
| Gross Profit | -- | -- | -- | -- | 136.86% |
| SG&A Expenses | 35.44% | 16.13% | 93.09% | 93.09% | 276.09% |
| Depreciation & Amortization | -- | -- | 375.00% | 375.00% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -73.44% | -45.81% | -84.69% | -84.69% | 224.17% |
| Operating Income | -188.78% | -33.02% | -169.22% | -169.22% | 90.61% |
| Income Before Tax | -186.63% | -33.53% | -169.55% | -169.55% | 95.99% |
| Income Tax Expenses | -- | -- | -- | -- | 233.21% |
| Earnings from Continuing Operations | -210.08% | -0.36% | -157.43% | -157.43% | 17.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -210.08% | -0.36% | -157.43% | -157.43% | 17.39% |
| EBIT | -188.78% | -33.02% | -169.22% | -169.22% | 90.61% |
| EBITDA | -186.71% | -34.03% | -167.58% | -167.58% | -- |
| EPS Basic | -215.38% | 0.00% | -158.33% | -158.33% | 18.18% |
| Normalized Basic EPS | -181.82% | -50.00% | -162.50% | -162.50% | 120.00% |
| EPS Diluted | -215.38% | 0.00% | -158.33% | -158.33% | 18.18% |
| Normalized Diluted EPS | -181.82% | -50.00% | -162.50% | -162.50% | 120.00% |
| Average Basic Shares Outstanding | 0.25% | 0.52% | 0.52% | 0.52% | 0.54% |
| Average Diluted Shares Outstanding | 0.25% | 0.52% | 0.52% | 0.52% | 0.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |